Increased expression of p63 and survivin in cholesteatomas

Acta Oto-Laryngologica

Volumn 129, Issue 3, 2009, Pages 268-272

  Park, H R ^a   Min, S K ^a   Min, K ^a   Jun, S Y ^a   Seo, J ^a   Kim, H J ^a  

^a Hallym University   (South Korea)

Author keywords

Cholesteatoma; p63; Survivin

Indexed keywords

PROTEIN P63; SURVIVIN;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHOLESTEATOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; EAR SURGERY; EPITHELIUM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN;

CASE-CONTROL STUDIES; CHOLESTEATOMA, MIDDLE EAR; EAR, MIDDLE; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS;

EID: 61649122370     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480802251591     Document Type: Article

References (20)

1. Min WS, Jung HS, Park JY, Jun BH, Song GY. Immunohistochemical study on the expression of proliferative markers of the squamous epithelium of the cholesteatoma. Korean J Otolaryngol 1995;38:1884-92.
2. Sheikholeslam-Zadeh R, Decaestecker C, Delbrouck C, Danguy A, Salmon I, Zick Y, et al. The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas. Laryngoscope 2001;111:1042-7.
3. Huisman MA, De Heer E, Grote JJ. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis. Acta Otolaryngol 2003;123:377-82.
4. Albino AP, Reed JA, Bogdany JK, Sassoon J, Desloge RB, Parisier SC. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications. Am J Otol 1998;19:30-6.
5. Choufani G, Mahillon V, Decaestecker C, Lequeux T, Danguy A, Salmon I, et al. Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and nonrecurrent cholesteatomas. Laryngoscope 1999;109:1825-31.
6. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC. p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 2002;29:517-23.
7. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, et al. p63, a p53 homolog at 3q27, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-16.
8. Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L, et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 2000;157:1769-75.
9. Barbareschi M, Pecciarini L, Cangi MG, Macri E, Rizzo A, Viale G, et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001;25:1054-60.
10. Quade BJ, Yang A, Wang Y, Sun D, Park J, Sheets EE, et al. Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol 2001;80:24-9.
11. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398:714-8.
12. Chiodino C, Cesinaro AM, Ottani D, Fantini F, Giannetti A, Trentini GP, et al. Expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol 1999;113:415-8.
13. Ambrosini G, Adida C, Altieri DC. A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-21.
14. Yang A, McKeon F. p63 and p73: p53 mimics, menaes, and more. Nat Rev Mol Cell Biol 2000;1:199-207.
15. Tsujita-Kyutoku M, Kiuchi K, Danbara N, Yuri T, Senzaki H, Tsubura A. p63 expression in normal human epidermis and epidermal appendages and their tumors. J Cutan Pathol 2003;30:11-7.
16. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A, et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999;398:708-13.
17. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A 2000;97:13103-7.
18. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998;396:580-4.
19. Choufani G, Ghanooni R, Decaestecker C, Delbrouck K, Simon P, Schuring MP, et al. Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-β, and anti-apoptotic galectin-3. Laryngoscope 2001;111:1656-62.
20. Kojima H, Miyazaki H, Shiwa M, Tanaka Y, Moriyama H. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length. Laryngoscope 2001;111:867-73.